Effect of danefukang on symptoms and biomarkers in women with endometriosis
article
OA: diamond
CC0
⤵ 5 in-corpus citations
Abstract
OBJECTIVE: The purpose of this study was to observe the efficacy of Danefukang (DEFK) soft extract for the treatment of symptoms associated with endometriosis, and its effect on quality of life, the Self-rating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS) scores, and on levels of carbohydrate antigen (CA)-125, tumor necrosis factor (TNF)-α, and interleukin (IL)-6. MATERIALS AND METHODS: A total of 174 patients with endometriosis treated from January 2010 to December 2013 were randomly divided into a control group treated with mifepristone (n = 87) or DEFK (n = 87). Both groups were treated for 3 months. Symptoms, quality of life, SAS, SD scores, and levels of CA-125, TNF-α, and IL-6 were evaluated before and after treatment. RESULTS: = 4.215, P < 0.05). Treatment with DEFK resulted in a greater improvement in quality of life, SDS, and SAS scores compared with mifepristone (all, P < 0.05). DEFK treatment also resulted in a greater decrease of CA-125, TNF-α, and IL-6 levels compared with mifepristone (all, P < 0.05). CONCLUSION: Based on the current results - improved symptoms, attenuated depression and anxiety, and reduced the levels of pro-inflammatory cytokines and CA-125 -treatment with DEFK is a meaningful option for patients with endometriosis. DEFK fills an unmet need in the pharmacologic treatment of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis via openalex
- Clinical immunology<br>Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis via openalex
- Dysmenorrhea and endometriosis in young women. via openalex
- Effect of mifepristone in the different treatments of endometriosis via openalex
- Endometriosis and physical exercises: a systematic review via openalex
- Endometriosis still a challenge. via openalex
- Evaluation of Efficacy and Safety of Dan’e‐Fukang Soft Extract in the Treatment of Endometriosis: A Meta‐Analysis of 39 Randomized Controlled Trials Enrolling 5442 Patients via openalex
- Impact of endometriosis on quality of life, anxiety, and depression: an Austrian perspective via openalex
- Innovations in conservative endometriosis treatment: an updated review. via openalex
- Laparoscopic treatment of endometriosis and effects on quality of life: A retrospective study using the short form EHP-5 endometriosis specific questionnaire via openalex
- [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors]. via openalex
- Regulation of P21-Activated Kinase-4 by Progesterone and Tumor Necrosis Factor-α in Human Endometrium and Its Increased Expression in Advanced-Stage Endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The Complementary and Alternative Medicine for Endometriosis: A Review of Utilization and Mechanism via openalex
- Therapeutic effects of mifepristone combined withGestrinone on patients with endometriosis via openalex
- Tumor Necrosis Factor and Interleukin‐6 Gene Polymorphisms and Endometriosis Risk in Asians: A Systematic Review and Meta‐Analysis via openalex
- Tumor necrosis factor gene polymorphisms and endometriosis in Asians: a systematic review and meta-analysis via openalex
- Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (Review) via openalex
- Use of Mifepristone to Treat Endometriosis: A Review of Clinical Trials and Trial-Like Studies Conducted in China via openalex
- W6671857119 via openalex
- W6680857293 via openalex
- W6697753831 via openalex
- W6715391619 via openalex
- W1992451410 via openalex
- W6734648644 via openalex
- W2302047339 via openalex
- W2160609829 via openalex
- W2040612350 via openalex
- W6635732373 via openalex
Cited by (5)
- Bridging gaps in endometriosis care: a scoping review of complementary, alternative and/or integrative medicine for pain and quality of life 2025
- Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis 2023
- EXPLORING THE AMELIORATIVE EFFECTS OF HYPERICUM SCABRUM L. ON A SURGICALLY-INDUCED ENDOMETRIOSIS RAT MODEL AND ITS PHYTOCHEMICAL PROFILING BY LC-MS/MS 2023
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies 2020
- A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:54.901233+00:00
License: CC0
· commercial use OK